跳至主要内容
临床试验/ACTRN12622000616774
ACTRN12622000616774已完成未知

Efficacy and safety of olive leaf extract for glycaemic control in adults with type 2 diabetes mellitus (ESOLED): a pilot randomised controlled trial

ational Centre for Naturopathic Medicine, Southern Cross University0 个研究点目标入组 31 人开始时间: 2022年4月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Diagnosis of Type 2 Diabetes Mellitus (as diagnosed by a medical doctor or nurse)
  • 2.Diabetes of at least 12 months duration,
  • 3.Not receiving insulin therapy,
  • 4.Not received OLE within the previous 6 months,
  • 5.Able to provide written consent,
  • 6.Fluent in written and spoken English, and
  • 7.Aged 18 years or older.

排除标准

  • 1.History of any condition causing moderate to severe cognitive impairment (e.g. dementia, acquired brain injury),
  • 2.Known allergy to olives or olive leaf,
  • 3.Needle phobia or strong aversion to providing a blood sample,
  • 4.Known pregnancy and/or actively breastfeeding, or
  • 5.Participated in a clinical trial within the past 30 days.

研究者

发起方
ational Centre for Naturopathic Medicine, Southern Cross University

相似试验